Research-for-Cure Academy

Alfredo Tagarro

Nationality: Spanish
Institution: Fundación 12 de Octubre
Country of work: Spain

What is your motivation for engaging in HIV cure and remission research?

One of my earliest motivations for engaging into Medicine career was living the devastating effects of the 90s HIV epidemics. For me, HIV and its links with poverty has always been moving. The main goal of my current research job is HIV Cure in perinatally-infected infants. I coordinate a cohort of early-treated infants in South Africa and Mozambique. Our team is also aiming at writing a protocol for one cure proof-of-concept trial. Therefore, I have the utmost interest in cure strategies for these children. We hope that children enrolled in this cohort will have the chance of being enrolled in cure trials.

What is your current area of research?

I am a clinical researcher and pediatrician currently working for the EPIICAL Consortium (www.epiical.org). The project is led by PENTA-ID, and there are several partners from Europe, Africa and the USA. EPIICAL’s general goal is to understand and kill the reservoir in perinatally-infected children.

I am the coordinator of the cohort EARTH. EARTH is a cohort of early-treated infants in South Africa and Mozambique. We are working closely with clinicians, immunologists, virologists and social scientists. We intend to accelerate the process from the production of new therapies to the access of HIV children to these therapies, through clinical trials.